Cargando…

Prognostic Value of Body Mass Index on Short-Term and Long-Term Outcome after Resection of Esophageal Cancer

INTRODUCTION: Cachexia and obesity have been suggested to be risk factors for postoperative complications. However, high body mass index (BMI) might result in a higher R0-resection rate because of the presence of more fatty tissue surrounding the tumor. The purpose of this study was to investigate w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grotenhuis, B. A., Wijnhoven, B. P. L., Hötte, G. J., van der Stok, E. P., Tilanus, H. W., van Lanschot, J. J. B.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949552/ https://www.ncbi.nlm.nih.gov/pubmed/20596708 http://dx.doi.org/10.1007/s00268-010-0697-8

Ejemplares similares

Sarcopenia/Muscle Mass is not a Prognostic Factor for Short- and Long-Term Outcome After Esophagectomy for Cancer
por: Grotenhuis, Brechtje A., et al.
Publicado: (2016)

Delay in Diagnostic Workup and Treatment of Esophageal Cancer
por: Grotenhuis, Brechtje A., et al.
Publicado: (2009)

Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer
por: Talsma, Koen, et al.
Publicado: (2012)

Fixed Size of Enlarged Calcified Lymph Nodes in Esophageal Adenocarcinoma despite Complete Remission
por: Grotenhuis, B.A., et al.
Publicado: (2009)

Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Review of Meta-Analyses
por: Wijnhoven, Bas P. L., et al.
Publicado: (2009)

Characteristics Predicting Short-Term and Long-Term Health-Related Quality of Life in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy and Esophagectomy
por: van der Wilk, Berend J., et al.
Publicado: (2023)

Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples
por: van Nistelrooij, Anna M. J., et al.
Publicado: (2017)

Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: Long-term results of a randomized controlled trial
por: Boonstra, Jurjen J, et al.
Publicado: (2011)

Patients’ Preferences for Surgical Management of Esophageal Cancer: A Discrete Choice Experiment
por: de Bekker-Grob, Esther W., et al.
Publicado: (2015)

Short-Term Prognostic Index for Breast Cancer: NPI or Lpi
por: Van Belle, V., et al.
Publicado: (2010)

A single blinded randomized controlled trial comparing semi‐mechanical with hand‐sewn cervical anastomosis after esophagectomy for cancer (SHARE‐study)
por: Nederlof, Nina, et al.
Publicado: (2020)

Early onset esophageal adenocarcinoma: a distinct molecular entity?
por: van Nistelrooij, Anna M.J., et al.
Publicado: (2016)

Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?
por: Schreurs, L. M. A., et al.
Publicado: (2011)

Long-term and short-term prognostic value of the prognostic nutritional index in cancer: a narrative review
por: Yan, Li, et al.
Publicado: (2021)

Single nucleotide polymorphisms in CRTC1 and BARX1 are associated with esophageal adenocarcinoma
por: van Nistelrooij, Anna M. J., et al.
Publicado: (2015)

The effectivity of targeted therapy and immunotherapy in patients with advanced metastatic and non-metastatic cancer of the esophagus and esophago-gastric junction
por: Valkema, M. J., et al.
Publicado: (2022)

Quality of Life During and After Completion of Neoadjuvant Chemoradiotherapy for Esophageal and Junctional Cancer
por: Noordman, B. J., et al.
Publicado: (2019)

Techniques and short-term outcomes for total minimally invasive Ivor Lewis esophageal resection in distal esophageal and gastroesophageal junction cancers: pooled data from six European centers
por: Straatman, Jennifer, et al.
Publicado: (2016)

High-Volume versus Low-Volume for Esophageal Resections for Cancer: The Essential Role of Case-Mix Adjustments based on Clinical Data
por: Wouters, Michael W., et al.
Publicado: (2007)

Germline variant in MSX1 identified in a Dutch family with clustering of Barrett’s esophagus and esophageal adenocarcinoma
por: van Nistelrooij, A. M. J., et al.
Publicado: (2017)

The Impact of Signet Ring Cell Differentiation on Outcome in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma
por: van Hootegem, Sander J. M., et al.
Publicado: (2019)

Resection of hepatic and pulmonary metastasis from metastatic esophageal and gastric cancer: a nationwide study
por: Seesing, M F J, et al.
Publicado: (2019)

Multimodality treatment for esophageal adenocarcinoma: multi-center propensity-score matched study
por: Markar, S. R., et al.
Publicado: (2017)

A High Body Mass Index in Esophageal Cancer Patients Does Not Influence Postoperative Outcome or Long-Term Survival
por: Blom, R. L. G. M., et al.
Publicado: (2011)

Preoperative prognostic nutritional index predicts short-term complications after radical resection of distal cholangiocarcinoma
por: He, Yulong, et al.
Publicado: (2023)

Preoperative and Early Postoperative Quality of Life Predict Survival in Potentially Curable Patients with Esophageal Cancer
por: van Heijl, Mark, et al.
Publicado: (2009)

Using the Comprehensive Complication Index to Assess the Impact of Neoadjuvant Chemoradiotherapy on Complication Severity After Esophagectomy for Cancer
por: Nederlof, Nina, et al.
Publicado: (2016)

Centralization of Esophageal Cancer Surgery: Does It Improve Clinical Outcome?
por: Wouters, M. W. J. M., et al.
Publicado: (2009)

FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review
por: Omloo, J. M. T., et al.
Publicado: (2011)

Charlson comorbidity index as a predictor of short-term outcomes after pulmonary resection
por: Shao, Weipeng, et al.
Publicado: (2020)

Impact of Body Mass Index on Short-Term Outcomes in Patients Undergoing Percutaneous Coronary Intervention in Newfoundland and Labrador, Canada
por: Gregory, Anne B., et al.
Publicado: (2016)

Prognostic Value of the Circumferential Resection Margin in Esophageal Cancer Patients After Neoadjuvant Chemoradiotherapy
por: Hulshoff, J. B., et al.
Publicado: (2015)

Association between Paclitaxel Clearance and Tumor Response in Patients with Esophageal Cancer
por: Toxopeus, Eelke L.A., et al.
Publicado: (2019)

Outcome of Patients Treated Within and Outside a Randomized Clinical Trial on Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: Extrapolation of a Randomized Clinical Trial (CROSS)
por: Toxopeus, Eelke, et al.
Publicado: (2018)

Human oesophageal adenocarcinoma cell lines JROECL 47 and JROECL 50 are admixtures of the human colon carcinoma cell line HCT 116
por: Wijnhoven, B P L, et al.
Publicado: (2000)

Short-term survival in extensive craniofacial resections
por: Leite, Ana Kober N., et al.
Publicado: (2021)

The association and prognostic value of systemic inflammatory response index with short and long-term mortality in patients with sepsis
por: Ru, Shuyan, et al.
Publicado: (2023)

Olfactomedin 4 (OLFM4) expression is associated with nodal metastases in esophageal adenocarcinoma
por: Suzuki, Lucia, et al.
Publicado: (2019)

Conversion of laparoscopic colorectal resection for cancer: What is the impact on short-term outcomes and survival?
por: Allaix, Marco E, et al.
Publicado: (2016)

Pattern of p53 protein expression is predictive for survival in chemoradiotherapy-naive esophageal adenocarcinoma
por: Ten Kate, Fiebo J.C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_i0hg5tu7e4hm849raflhfohv5g